Technical challenges in using human induced pluripotent stem cells to model disease.
about
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cellsNeurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutationHuman Embryonic Stem Cells: A Model for the Study of Neural Development and Neurological DiseasesThe Application of Human iPSCs in Neurological Diseases: From Bench to BedsideModeling Kidney Disease with iPS CellsCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsMolecular roadblocks for cellular reprogrammingPluripotent stem cells models for Huntington's disease: prospects and challengesInduced pluripotent stem cells as a disease modeling and drug screening platformProceedings: consideration of genetics in the design of induced pluripotent stem cell-based models of complex diseaseModeling neurological disorders by human induced pluripotent stem cellsDeveloping defined culture systems for human pluripotent stem cellsFunctional Coupling with Cardiac Muscle Promotes Maturation of hPSC-Derived Sympathetic Neurons.Engineering three-dimensional stem cell morphogenesis for the development of tissue models and scalable regenerative therapeutics.A review of Rett syndrome (RTT) with induced pluripotent stem cellsTranslational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug DiscoveryUrine-derived induced pluripotent stem cells as a modeling tool to study rare human diseasesCytoplast containing reprogramming-related factors from human embryonic stem cells arrested at metaphaseNon-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cellsGeneration of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectorsCell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cellsStem cell therapy for the inner ear: recent advances and future directions.Stem cell biology and drug discovery.Systematic search for recipes to generate induced pluripotent stem cellsNew iPSC for old long QT syndrome modeling: putting the evidence into perspective.Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.Generation of induced Pluripotent Stem Cells as disease modelling of NLSDMThe LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cellsOlfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomiaRecipes and mechanisms of cellular reprogramming: a case study on budding yeast Saccharomyces cerevisiae.Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs.Neurotrophic factor GDNF promotes survival of salivary stem cellsIn vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors.The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stressDiscovering small molecules to control stem cell fate.CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues.Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytesDifferentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian ratsRecent technological updates and clinical applications of induced pluripotent stem cells
P2860
Q24339508-3D1BD3A7-D3BD-458A-B430-D6575DA53558Q24620932-C98B1C98-C9E1-4A06-A5FF-333FB18F1E06Q26269852-910045C8-8A57-4C85-8AD7-C5DEAA6FA222Q26745433-1CA9F3EE-1F79-4268-91BC-E11B3CB32E5DQ26765876-E5123414-84F5-4D72-B36A-B7586B3E8B65Q26770384-AF052A90-6D22-440C-A9AD-F1A71498F610Q26798131-E5C05995-574F-4F86-9916-63CE7E595C1CQ26822585-E5095716-21C3-4D57-97A4-493789BCAAFAQ26860151-783ABC5A-57BE-462A-AFB4-3FA103EA53F9Q26865689-4328B56B-487B-47DF-AB83-4D2C9DBB34DCQ26999033-6F3804C5-AEFC-46B5-99A9-C945103CD00AQ27011777-161E190D-2B91-4F36-BE0A-E293DE96DCE1Q27021126-A80DF87C-4465-442E-A6D9-7ED8D4D0FFE0Q27303646-CA094824-40A0-4D20-AEA7-9B455AE618F0Q27692626-286CE79F-884E-48ED-9590-743EE8718C93Q28072303-D50901DB-8099-4F67-8726-ACD4A29E7AC4Q28072402-6AF3CA74-AED9-47AE-AB63-277BC9A1392EQ28073204-0BABA07E-C8F3-4015-A06E-0597AA30BFE2Q28303916-81B3651C-5F40-4DC0-8501-A33AE1895170Q28601391-DDC974B4-8CD2-4048-964E-1A722942C5CCQ28742368-0DE25AB8-C92C-49A8-AB13-8978B71EE4FCQ29619469-DBFF24F4-4A60-4476-A896-8E2377EC9362Q30424817-85305748-F4D4-4920-B3C9-8DC78365B583Q31017177-27647FDF-1781-414C-AD65-5551EB8B1B31Q31044390-8949D973-B431-4F75-8465-DFD1C0F3336FQ33163663-A0A6F4E6-3A14-4794-813D-38CA75933E00Q33672762-506E3079-8A4D-455E-8E9B-C3DA7CE8C6A9Q33695645-A4A75116-66A1-4A69-95CE-94C8A5DA8EABQ33741989-90605217-F371-4FB4-9F6B-218FA850C1CEQ33781178-56D0BA12-FAA0-4123-9829-8B7B5226C74EQ33870609-81758471-6D8B-4529-951C-DE4FE0E0C482Q33927236-D9C95062-E34E-4B6C-8316-E98685A409C8Q33944235-F0739E76-6C74-489F-82AD-E29C02CF39C3Q33951804-3C370183-CF12-4C6C-90E0-B576F61A5869Q33984724-9A3EA1CE-DA3D-49B0-906D-7CA034B93FB0Q34007289-DF298C7B-D015-4A41-ADD8-62973F3EE555Q34047602-7CA09EEE-748A-44A8-9284-720514AA74AEQ34078669-C96B596A-FEA8-48DC-B42E-A078DB1DEA46Q34115609-DAB6EBB3-2677-4E57-913B-39AD58D60634Q34184553-E6B3AFAF-A30D-4312-8D8A-D2C7B155CDA7
P2860
Technical challenges in using human induced pluripotent stem cells to model disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Technical challenges in using human induced pluripotent stem cells to model disease.
@en
Technical challenges in using human induced pluripotent stem cells to model disease.
@nl
type
label
Technical challenges in using human induced pluripotent stem cells to model disease.
@en
Technical challenges in using human induced pluripotent stem cells to model disease.
@nl
prefLabel
Technical challenges in using human induced pluripotent stem cells to model disease.
@en
Technical challenges in using human induced pluripotent stem cells to model disease.
@nl
P2860
P1433
P1476
Technical challenges in using human induced pluripotent stem cells to model disease.
@en
P2860
P304
P356
10.1016/J.STEM.2009.11.009
P407
P577
2009-12-01T00:00:00Z